Literature DB >> 18185097

ErbB4 is a suppressor of long-term potentiation in the adult hippocampus.

Graham M Pitcher1, Simon Beggs, Ran-Sook Woo, Lin Mei, Michael W Salter.   

Abstract

ErbB4 has emerged as a leading susceptibility gene for schizophrenia but the function of the ErbB4 receptor in the adult brain is unknown. Here, we show in the adult hippocampus that long-term potentiation (LTP) of transmission at Schaffer collateral CA1 synapses was markedly enhanced in mutant mice lacking ErbB4. Concordantly, LTP was enhanced by acutely blocking ErbB4 in wild-type animals, indicating that ErbB4 activity constitutively suppresses LTP. Moreover, increasing ErbB4 signaling further suppressed LTP. By contrast, altering ErbB4 activity did not affect basal synaptic transmission or short-term facilitation. Our findings suggest that cognitive deficits in schizophrenia may be a consequence of hyperfunction of ErbB4 signaling leading to suppressed glutamatergic synaptic plasticity, thus opening new approaches for the treatment of this disorder.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18185097      PMCID: PMC3707840          DOI: 10.1097/WNR.0b013e3282f3da10

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  25 in total

1.  First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients.

Authors:  L S Pilowsky; R A Bressan; J M Stone; K Erlandsson; R S Mulligan; J H Krystal; P J Ell
Journal:  Mol Psychiatry       Date:  2006-02       Impact factor: 15.992

2.  Schizophrenia genes - famine to feast.

Authors:  Richard E Straub; Daniel R Weinberger
Journal:  Biol Psychiatry       Date:  2006-07-15       Impact factor: 13.382

3.  Further evidence for association between ErbB4 and schizophrenia and influence on cognitive intermediate phenotypes in healthy controls.

Authors:  K K Nicodemus; A Luna; R Vakkalanka; T Goldberg; M Egan; R E Straub; D R Weinberger
Journal:  Mol Psychiatry       Date:  2006-12       Impact factor: 15.992

4.  Modeling of context-dependent retrieval in hippocampal region CA1: implications for cognitive function in schizophrenia.

Authors:  Peter J Siekmeier; Michael E Hasselmo; Marc W Howard; Joseph Coyle
Journal:  Schizophr Res       Date:  2006-10-20       Impact factor: 4.939

5.  Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia.

Authors:  Chang-Gyu Hahn; Hoau-Yan Wang; Dan-Sung Cho; Konrad Talbot; Raquel E Gur; Wade H Berrettini; Kalindi Bakshi; Joshua Kamins; Karin E Borgmann-Winter; Steven J Siegel; Robert J Gallop; Steven E Arnold
Journal:  Nat Med       Date:  2006-06-11       Impact factor: 53.440

Review 6.  Translational and developmental perspective on N-methyl-D-aspartate synaptic deficits in schizophrenia.

Authors:  Angus W MacDonald; Matthew V Chafee
Journal:  Dev Psychopathol       Date:  2006

7.  Neuregulin-1 reverses long-term potentiation at CA1 hippocampal synapses.

Authors:  Oh-Bin Kwon; Marines Longart; Detlef Vullhorst; Dax A Hoffman; Andres Buonanno
Journal:  J Neurosci       Date:  2005-10-12       Impact factor: 6.167

8.  Neuregulin1 (NRG1) signaling through Fyn modulates NMDA receptor phosphorylation: differential synaptic function in NRG1+/- knock-outs compared with wild-type mice.

Authors:  Maria Bjarnadottir; Dinah L Misner; Sascha Haverfield-Gross; Silas Bruun; Vignir G Helgason; Hreinn Stefansson; Arnar Sigmundsson; David R Firth; Berit Nielsen; Ragnheidur Stefansdottir; Thomas J Novak; Kari Stefansson; Mark E Gurney; Thorkell Andresson
Journal:  J Neurosci       Date:  2007-04-25       Impact factor: 6.167

9.  Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia.

Authors:  Amanda J Law; Joel E Kleinman; Daniel R Weinberger; Cynthia Shannon Weickert
Journal:  Hum Mol Genet       Date:  2006-12-12       Impact factor: 6.150

10.  Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia.

Authors:  Nadine Norton; Valentina Moskvina; Derek W Morris; Nicholas J Bray; Stanley Zammit; Nigel M Williams; Hywel J Williams; Anna C Preece; Sarah Dwyer; Jennifer C Wilkinson; Gillian Spurlock; George Kirov; Paul Buckland; John L Waddington; Michael Gill; Aiden P Corvin; Michael J Owen; Michael C O'Donovan
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-01-05       Impact factor: 3.568

View more
  45 in total

Review 1.  Dysregulated Src upregulation of NMDA receptor activity: a common link in chronic pain and schizophrenia.

Authors:  Michael W Salter; Graham M Pitcher
Journal:  FEBS J       Date:  2011-12-05       Impact factor: 5.542

Review 2.  Pharmacological therapies for Angelman syndrome.

Authors:  Wen-Hann Tan; Lynne M Bird
Journal:  Wien Med Wochenschr       Date:  2016-01-12

Review 3.  Non-coding RNA regulation of synaptic plasticity and memory: implications for aging.

Authors:  Laurie R Earls; Joby J Westmoreland; Stanislav S Zakharenko
Journal:  Ageing Res Rev       Date:  2014-03-27       Impact factor: 10.895

Review 4.  Concise review: the promise of human induced pluripotent stem cell-based studies of schizophrenia.

Authors:  Kristen J Brennand; Fred H Gage
Journal:  Stem Cells       Date:  2011-12       Impact factor: 6.277

5.  Dynamic ErbB4 Activity in Hippocampal-Prefrontal Synchrony and Top-Down Attention in Rodents.

Authors:  Zhibing Tan; Heath L Robinson; Dong-Min Yin; Yu Liu; Fang Liu; Hongsheng Wang; Thiri W Lin; Guanglin Xing; Lin Gan; Wen-Cheng Xiong; Lin Mei
Journal:  Neuron       Date:  2018-04-05       Impact factor: 17.173

6.  Specific regulation of NRG1 isoform expression by neuronal activity.

Authors:  Xihui Liu; Ryan Bates; Dong-Min Yin; Chengyong Shen; Fay Wang; Nan Su; Sergei A Kirov; Yuling Luo; Jian-Zhi Wang; Wen-Cheng Xiong; Lin Mei
Journal:  J Neurosci       Date:  2011-06-08       Impact factor: 6.167

7.  Neuregulin-1 impairs the long-term depression of hippocampal inhibitory synapses by facilitating the degradation of endocannabinoid 2-AG.

Authors:  Huizhi Du; In-Kiu Kwon; Jimok Kim
Journal:  J Neurosci       Date:  2013-09-18       Impact factor: 6.167

8.  ErbB4-neuregulin signaling modulates synapse development and dendritic arborization through distinct mechanisms.

Authors:  Daria Krivosheya; Lucia Tapia; Joshua N Levinson; Kun Huang; Yunhee Kang; Rochelle Hines; Annie K Ting; Ann Marie Craig; Lin Mei; Shernaz X Bamji; Alaa El-Husseini
Journal:  J Biol Chem       Date:  2008-09-26       Impact factor: 5.157

9.  Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons.

Authors:  Lei Wen; Yi-Sheng Lu; Xin-Hong Zhu; Xiao-Ming Li; Ran-Sook Woo; Yong-Jun Chen; Dong-Min Yin; Cary Lai; Alvin V Terry; Almira Vazdarjanova; Wen-Cheng Xiong; Lin Mei
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-29       Impact factor: 11.205

10.  Reversal of behavioral deficits and synaptic dysfunction in mice overexpressing neuregulin 1.

Authors:  Dong-Min Yin; Yong-Jun Chen; Yi-Sheng Lu; Jonathan C Bean; Anupama Sathyamurthy; Chengyong Shen; Xihui Liu; Thiri W Lin; Clifford A Smith; Wen-Cheng Xiong; Lin Mei
Journal:  Neuron       Date:  2013-05-22       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.